Clinical trials
Active, not recruiting Overweight trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 13 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 6 |
| Amgen | 3 |
| Kailera | 2 |
| Pfizer | 2 |
| West German Center of Diabetes and Health | 2 |
| AstraZeneca | 1 |
| German Institute of Human Nutrition | 1 |
| Hoffmann-La Roche | 1 |
| Novo Nordisk A/S | 1 |
| University of Erlangen-Nürnberg Medical School | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 20 |
| Obesity | 18 |
| Diabetes Mellitus, Type 2 | 7 |
| Body Weight | 2 |
| Diabetes Mellitus | 2 |
| Fatty Liver | 2 |
| Hypertension | 2 |
| Non-alcoholic Fatty Liver Disease | 2 |
| Weight Loss | 2 |
| Diabetes Mellitus, Type 1 | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.